Olynyk John K, St Pierre Timothy G, Chen James, Frazer David M, Ramm Louise E, Ramm Grant A
Curtin Medical School, Curtin University, Bentley, Western Australia, Australia.
Department of Gastroenterology, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
Gastro Hep Adv. 2024 Jan 24;3(4):454-460. doi: 10.1016/j.gastha.2024.01.011. eCollection 2024.
Hemostatic iron regulator-hemochromatosis can result in progressive iron-loading and advanced hepatic fibrosis in some individuals. We studied total body and hepatic iron loading to determine whether the distribution of iron-loading influences the risk of advanced fibrosis.
One hundred thirty-eight men and 66 women with hemochromatosis who underwent liver biopsy for staging of hepatic fibrosis had evaluation of hepatic iron concentration (HIC), hepatic iron index (HIC/age), total body iron stores (mobilizable iron), and mobilizable iron/HIC ratio (a marker of total body iron relative to hepatic iron). The potential impact of liver volume on mobilizable iron stores was assessed using magnetic resonance imaging in a separate cohort of 19 newly diagnosed individuals with hemochromatosis.
Of 204 biopsied subjects, 41 had advanced fibrosis and exhibited 60% greater accumulation of mobilizable iron relative to HIC (mean 0.070 ± 0.008 g Fe/[μmol Fe/g]) compared with 163 subjects with low-grade fibrosis (mean 0.044 ± 0.002 g Fe/[μmol Fe/g], < .0001). Linear regression modeling confirmed a discrete advanced hepatic fibrosis phenotype associated with greater mobilizable iron stores relative to HIC. The ratios of the upper to lower 95% limits of the distributions of liver volumes and the mobilizable iron/HIC ratios were 2.7 (95% confidence interval 2.3-3.0) and 9.7 (95% confidence interval 8.0-11.7), respectively, indicating that the distribution of liver volumes is not sufficiently wide to explain the variability in mobilizable iron/HIC ratios, suggesting that significant extrahepatic iron loading is present in those with advanced hepatic fibrosis.
Advanced hepatic fibrosis develops in hemostatic iron regulator-hemochromatosis individuals who also have excessive extrahepatic mobilizable iron stores.
止血性铁调节蛋白 - 血色素沉着症在某些个体中可导致进行性铁负荷增加和晚期肝纤维化。我们研究了全身和肝脏的铁负荷情况,以确定铁负荷的分布是否会影响晚期纤维化的风险。
138名男性和66名患有血色素沉着症且接受肝活检以进行肝纤维化分期的女性,对其进行了肝铁浓度(HIC)、肝铁指数(HIC/年龄)、全身铁储存(可动员铁)以及可动员铁/HIC比值(全身铁相对于肝脏铁的标志物)的评估。在另一组19名新诊断的血色素沉着症个体中,使用磁共振成像评估肝脏体积对可动员铁储存的潜在影响。
在204名接受活检的受试者中,41名患有晚期纤维化,与163名低级别纤维化受试者相比,其可动员铁相对于HIC的积累量高60%(平均0.070±0.008 g Fe/[μmol Fe/g] 对比平均0.044±0.002 g Fe/[μmol Fe/g],P <.0001)。线性回归模型证实了一种与相对于HIC更高的可动员铁储存相关的离散晚期肝纤维化表型。肝脏体积分布的95%上限与下限之比以及可动员铁/HIC比值分布的95%上限与下限之比分别为2.7(95%置信区间2.3 - 3.0)和9.7(95%置信区间8.0 - 11.7),这表明肝脏体积分布不够宽泛,无法解释可动员铁/HIC比值的变异性,提示晚期肝纤维化患者存在显著的肝外铁负荷。
在止血性铁调节蛋白 - 血色素沉着症个体中,晚期肝纤维化的发生与肝外可动员铁储存过多有关。